{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:18:21Z","timestamp":1774538301095,"version":"3.50.1"},"reference-count":28,"publisher":"EDP Sciences","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/www.edpsciences.org\/en\/authors\/copyright-and-licensing"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>La COVID-19 est une infection pand\u00e9mique \u00e9mergente dont l\u2019importante capacit\u00e9 \u00e0 se propager dans une population d\u00e9nu\u00e9e d\u2019immunit\u00e9 n\u2019est plus \u00e0 prouver. La premi\u00e8re r\u00e9ponse des \u00c9tats \u00e0 la flamb\u00e9e de COVID-19 fut d\u2019imposer un confinement et des mesures barri\u00e8res, telles que le port du masque et la<jats:italic>distanciation sociale<\/jats:italic>. Une des r\u00e9percussions de cette pand\u00e9mie, en mati\u00e8re de sant\u00e9 publique, fut la suspension ou le ralentissement brusque des campagnes de vaccination des nourrissons, un peu partout dans le monde. Un des effets indirects de la COVID-19 est donc le risque de peser sur la mortalit\u00e9 mondiale, principalement<jats:italic>via<\/jats:italic>une recrudescence de la rougeole et de la poliomy\u00e9lite, principalement dans les pays en voie de d\u00e9veloppement. Dans ce chaos potentiel, le seul espoir r\u00e9side dans le d\u00e9veloppement rapide d\u2019un vaccin efficace contre le SARS-CoV-2 (<jats:italic>severe acute respiratory syndrome<\/jats:italic>-<jats:italic>coronavirus-2<\/jats:italic>). Cependant, l\u2019acceptation de ce vaccin par la population n\u2019est pas \u00e9vidente, car outre les nombreuses inconnues qui vont peser in\u00e9vitablement dans le cas d\u2019un d\u00e9veloppement tr\u00e8s rapide du vaccin, le scepticisme des h\u00e9sitants vaccinaux va \u00e0 nouveau se d\u00e9velopper.<\/jats:p>","DOI":"10.1051\/medsci\/2020203","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T13:01:23Z","timestamp":1604581283000},"page":"1034-1037","source":"Crossref","is-referenced-by-count":15,"title":["COVID-19 et vaccination : une d\u00e9r\u00e9gulation globale"],"prefix":"10.1051","volume":"36","author":[{"given":"Emmanuelle","family":"Billon-Denis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4542-2421","authenticated-orcid":false,"given":"Jean-Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"R1","unstructured":"Avis n\u00b0 2020.0025\/AC\/SEESP du 1eravril 2020 du coll\u00e8ge de la Haute autorit\u00e9 de sant\u00e9 relatif au maintien de la vaccination des nourrissons dans le contexte de l\u2019\u00e9pid\u00e9mie de COVID-19. Haute autorit\u00e9 de sant\u00e9 (HAS), 2020. https:\/\/www.has-sante.fr\/jcms\/p_3169084\/fr\/avis-n-2020-0025\/ac\/seesp-du-1er-avril-2020-du-college-de-la-haute-autorite-de-sante-relatif-au-maintien-de-la-vaccination-des-nourrissons-dans-le-contexte-de-l-epidemie-de-covid-19."},{"key":"R2","unstructured":"Calendrier vaccinal des nourrissons et COVID-19. Paris : Acad\u00e9mie Nationale de M\u00e9decine, 2020\u00bb http:\/\/www.academie-medecine.fr\/wp-content\/uploads\/2020\/04\/Calendrier-vaccinal-des-nourrissons-et-COVID-19.pdf."},{"key":"R3","unstructured":"Weill A, Drouin J, Desplas D, et al. Usage des m\u00e9dicaments de ville en France durant l\u2019\u00e9pid\u00e9mie de Covid-19: point de situation apr\u00e8s 5 semaines de confinement. \u00c9tude pharmaco-\u00e9pid\u00e9miologique \u00e0 partir des donn\u00e9es de remboursement du SNDS. EPIPHARE rapport 2. Paris : ANSM, 2020. https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Usage-des-medicaments-en-ville-durant-l-epidemie-de-Covid-19-point-de-situation-apres-cinq-semaines-de-confinement-Point-d-information."},{"key":"R4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/514015a","volume":"514","author":"Check Hayden","year":"2014","journal-title":"Nature"},{"key":"R5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(20)30304-2","volume":"20","author":"Nelson","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"R7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.369.6506.892","volume":"369","author":"Roberts","year":"2020","journal-title":"Science"},{"key":"R8","unstructured":"Guiding principles for immunization activities during the COVID-19 pandemic. Interim guidance. Gen\u00e8ve : WHO, 2020."},{"key":"R9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.abc8637","volume":"369","author":"Guha-Sapir","year":"2020","journal-title":"Science"},{"key":"R10","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/S2214-109X(20)30229-1","volume":"8","author":"Roberton","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/d41573-020-00151-8","volume":"19","author":"Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"R12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"R13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Logunov DY, Dolzhikova IV, Zubkova OV, et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia. Lancet 2020; doi.org\/10.1016\/S0140-6736(20)31866-3-.","DOI":"10.1016\/S0140-6736(20)31866-3"},{"key":"R15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/d41586-020-02619-4","volume":"585","author":"Abbott","year":"2020","journal-title":"Nature"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Keech C, Albert G, Cho I, et al. Phase 1\u20132 trial of a SARS-CoV-2 recombinant Spike protein nanoparticle vaccine. N Engl J Med 2020; Doi:10.1056\/NEJMoa2026920.","DOI":"10.1056\/NEJMoa2026920"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2 \u2013 preliminary report. N Engl J Med 2020; doi: 10.1056\/NEJMoa2022483.","DOI":"10.1056\/NEJMoa2022483"},{"key":"R18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1051\/medsci\/2019143","volume":"35","author":"Pitard","year":"2019","journal-title":"Med Sci (Paris)"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Mulligan MJ, Lyke KE, Kitchin N, et al. Phase 1\/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 2020; 12 August.","DOI":"10.1038\/s41586-020-2639-4"},{"key":"R20","unstructured":"Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses. Nature 2020; 30 September."},{"key":"R21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(20)31611-1","volume":"396","author":"Bar-Zeev","year":"2020","journal-title":"Lancet"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Vaidyanathan G. India will supply coronavirus vaccines to the world: will its people benefit? Nature 2020; doi: 10.1038\/d41586-020-02507-x.","DOI":"10.1038\/d41586-020-02507-x"},{"key":"R23","unstructured":"https:\/\/www.covireivac.fr."},{"key":"R24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(20)30426-6","volume":"20","author":"Group","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R25","unstructured":"Expectations for a COVID-19 Vaccine. Chicago : Associated Press-NORC Center for Public Affairs Research, 2020."},{"key":"R26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1126\/science.abe4440","volume":"369","author":"Caplan","year":"2020","journal-title":"Science"},{"key":"R27","unstructured":"Strat\u00e9gie de vaccination contre le COVID-19. Anticipation des sc\u00e9narios possibles de vaccination et recommandations pr\u00e9liminaires sur les populations cibles. Saint-Denis : Haute Autorit\u00e9 de Sant\u00e9 (HAS), 2020. https:\/\/www.has-sante.fr\/jcms\/p_3197106\/fr\/strategie-de-vaccination-contre-le-covid-19-anticipation-des-scenarios-possibles-de-vaccination-et-recommandations-preliminaires-sur-les-populations-cibles."},{"key":"R28","unstructured":"Barr\u00e9-Sinoussi F, Atlani-Duault L, Muller S, et al. Vaccins contre le SARS-CoV-2. 9 juillet 2020. Une strat\u00e9gie de vaccination. Paris : Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9, 2020. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/avis_vaccins_9_juillet_2020_-_care_-_conseil_scientifique_-_comite_vaccin.pdf."}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2020203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T18:55:00Z","timestamp":1618253700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2020203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":28,"journal-issue":{"issue":"11"},"alternative-id":["msc200259"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2020203","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}